Leggett Thomas 4
4 · Stoke Therapeutics, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-03-20+89,000→ 89,000 totalExercise: $8.33Exp: 2035-03-19→ Common Stock (89,000 underlying) - Award
Restricted Stock Units
2025-03-20+59,000→ 59,000 totalExp: 2029-03-20→ Common Stock (59,000 underlying)
Footnotes (3)
- [F1]The option shall vest as to 1/48 of the total award on April 15, 2025, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The award vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the issuer through each vesting date.